Counterclaims Dropped In Merck-Sandoz Patent Suit
A judge has dismissed some of Sandoz Inc.'s counterclaims against Merck & Co. Inc. in a patent dispute over Sandoz's plans for a generic version of Merck's anti-nausea drug Emend....To view the full article, register now.
Already a subscriber? Click here to view full article